Cathie Wood Watch: Ark Buys a Fascinating Tech Stock, More Biotech

Renowned investor Cathie Wood, chief executive of Ark Investment Management, on Tuesday continued her recent patterns, buying biotechnology stocks, a spectrometry stock, a 3D printer maker and a robotics-software stock.

She also sold a financial technology stock. (All the valuations below are as of Tuesday’s close.)

Ark Genomic Revolution ETF  (ARKG) – Get ARK Genomic Revolution ETF Report purchased 119,876 shares of biotech company Personalis  (PSNL) – Get Personalis, Inc. Report, valued at $890,679. 

Source: https://www.thestreet.com/investing/cathie-wood-ark-spectrometry-biotech-stocks?puc=yahoo&cm_ven=YAHOO&yptr=yahoo